Who owns Harvard Bioscience?
- Ticker: HBIO
- CUSIP Number: 416906105
Tip: Access positions for across all investors
Analyze quarterly positions in Harvard Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Harvard Bioscience stock
Who bought or sold Harvard Bioscience this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Punch & Associates Investment Management | 2.9M | $16M | 0% | Dec 2023 |
|
B. Riley Asset Management | 2.8M | $12M | -4% | Mar 2024 |
|
BlackRock | 2.8M | $12M | 3% | Mar 2024 |
|
Harvey Partners | 2.6M | $11M | 0% | Mar 2024 |
|
AMH Equity | 2.3M | $9.9M | 7% | Mar 2024 |
|
Vanguard Group | 2.2M | $9.1M | 2% | Mar 2024 |
|
Dimensional Fund Advisors | 1.9M | $8.2M | 0% | Mar 2024 |
|
Granahan Investment Management | 1.9M | $7.9M | 7% | Mar 2024 |
|
Royce & Associates | 1.3M | $5.7M | -7% | Mar 2024 |
|
Boothbay Fund Management | 1.3M | $5.7M | 5% | Mar 2024 |
|
Acadian Asset Management | 1.0M | $4.3M | -6% | Mar 2024 |
|
Heartland Advisors | 889k | $3.8M | 3% | Mar 2024 |
|
Geode Capital Management | 856k | $3.6M | 10% | Mar 2024 |
|
Meros Investment Management | 822k | $3.5M | 0% | Mar 2024 |
|
Portolan Capital Management | 698k | $3.0M | 4% | Mar 2024 |
|
Northern Trust | 456k | $1.9M | -2% | Mar 2024 |
|
Acuitas Investments | 327k | $1.4M | 0% | Mar 2024 |
|
Kennedy Capital Management | 322k | $1.4M | -1% | Mar 2024 |
|
Bard Associates | 291k | $1.2M | 2% | Mar 2024 |
|
Bank of New York Mellon | 243k | $1.0M | -3% | Mar 2024 |
|
Charles Schwab Investment Management | 230k | $974k | -3% | Mar 2024 |
|
Greenwood Capital Associates | 217k | $918k | -2% | Mar 2024 |
|
Bridgeway Capital Management | 185k | $782k | -7% | Mar 2024 |
|
New York State Common Retirement Fund | 178k | $756k | 25% | Mar 2024 |
|
Pasadena Private Wealth | 173k | $731k | 0% | Mar 2024 |
|
Connor, Clark & Lunn Investment Management | 144k | $611k | 2% | Mar 2024 |
|
Nuveen Asset Management | 140k | $594k | 0% | Mar 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 115k | $488k | 10% | Mar 2024 |
|
ClariVest Asset Management | 111k | $471k | -23% | Mar 2024 |
|
Riverwater Partners | 93k | $395k | 14% | Mar 2024 |
|
Two Sigma Advisers | 88k | $374k | -16% | Mar 2024 |
|
Morgan Stanley | 80k | $339k | 40% | Mar 2024 |
|
Assenagon Asset Management | 78k | $329k | 0% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 76k | $322k | 39% | Mar 2024 |
|
Jacobs Levy Equity Management | 65k | $274k | -4% | Mar 2024 |
|
Winton Capital | 64k | $272k | 0% | Mar 2024 |
|
Two Sigma Investments | 42k | $178k | -21% | Mar 2024 |
|
UBS Group | 41k | $174k | -13% | Mar 2024 |
|
Goldman Sachs Group | 40k | $169k | -1% | Mar 2024 |
|
Rhumbline Advisers | 38k | $162k | 5% | Mar 2024 |
|
Legato Capital Management | 35k | $149k | 9% | Mar 2024 |
|
Barclays | 29k | $121k | -49% | Mar 2024 |
|
Hillsdale Investment Management | 26k | $112k | 100% | Mar 2024 |
|
Advisor Group Holdings | 25k | $107k | 25240% | Mar 2024 |
|
Citadel Advisors | 25k | $107k | 100% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 23k | $97k | 3% | Mar 2024 |
|
MetLife Investment Advisors | 21k | $111k | 0% | Dec 2023 |
|
American International | 20k | $108k | 1% | Dec 2023 |
|
Jane Street | 20k | $83k | 100% | Mar 2024 |
|
State of Wisconsin Investment Board | 19k | $82k | 100% | Mar 2024 |
|
Petrus Trust Company | 19k | $82k | -10% | Mar 2024 |
|
Millennium Management | 19k | $80k | -70% | Mar 2024 |
|
Engineers Gate Manager | 18k | $77k | -39% | Mar 2024 |
|
Jpmorgan Chase & Co | 17k | $71k | -39% | Mar 2024 |
|
Springbok Capital Management | 17k | $70k | -16% | Mar 2024 |
|
Franklin Resources | 16k | $69k | 0% | Mar 2024 |
|
O'shaughnessy Asset Management | 16k | $66k | -11% | Mar 2024 |
|
Ing Investment Management | 15k | $62k | -15% | Mar 2024 |
|
Camden Capital | 14k | $77k | 0% | Dec 2023 |
|
Triton Wealth Management, P | 13k | $50k | -50% | Mar 2024 |
|
Wells Fargo & Company | 13k | $56k | 14% | Mar 2024 |
|
Bailard | 13k | $56k | -33% | Mar 2024 |
|
T. Rowe Price Associates | 13k | $54k | 100% | Mar 2024 |
|
Janney Montgomery Scott | 11k | $47k | 1% | Mar 2024 |
|
Bank of America Corporation | 10k | $44k | -70% | Mar 2024 |
|
Citigroup | 7.5k | $32k | 17% | Mar 2024 |
|
Brown Shipley& Co | 4.7k | $20k | -1% | Mar 2024 |
|
Legal & General Group | 4.4k | $19k | 0% | Mar 2024 |
|
California State Teachers Retirement System | 4.1k | $17k | -54% | Mar 2024 |
|
Summit Investment Advisors | 3.2k | $14k | 0% | Mar 2024 |
|
Concord Wealth Partners | 2.3k | $9.5k | 100% | Mar 2024 |
|
Metropolitan Life Insurance Company | 2.2k | $12k | 0% | Dec 2023 |
|
Royal Bank of Canada | 1.4k | $5.5k | -89% | Mar 2024 |
|
Amalgamated Bank | 1.3k | $6.0k | -76% | Mar 2024 |
|
Baystate Wealth Management | 1.0k | $5.4k | 100% | Dec 2023 |
|
Nelson, Van Denburg & Campbell Wealth Management | 647.00 | $2.7k | 100% | Mar 2024 |
|
Tower Research Capital | 374.00 | $1.6k | -88% | Mar 2024 |
|
TSFG | 300.00 | $999.990000 | 0% | Mar 2024 |
|
Simplex Trading | 101.00 | $0 | -92% | Mar 2024 |
|
FMR | 59.00 | $250.000700 | 23% | Mar 2024 |
|
Qube Research & Technologies | 56.00 | $236.997600 | -100% | Mar 2024 |
|
Russell Investments | 54.00 | $228.997800 | 0% | Mar 2024 |
|
Who sold out of Harvard Bioscience?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
CornerCap Investment Counsel | Dec 2023 | 78k | $418k |
Landscape Capital Management | Dec 2023 | 29k | $157k |
Susquehanna International | Sep 2023 | 24k | $103k |
Mirae Asset Global Investments | Dec 2023 | 21k | $112k |
Algert Coldiron Investors | Sep 2023 | 21k | $90k |
Victory Capital Management | Dec 2023 | 18k | $97k |
Damian Sousa | Dec 2023 | 14k | $74k |
XTX Topco | Sep 2023 | 13k | $57k |
Florida State Board of Administration | Dec 2023 | 11k | $61k |
Dorsey Wright & Associates | Sep 2023 | 4.0k | $17k |
Financial Connections Group | Dec 2023 | 300.00 | $999.990000 |